GE Healthcare Optima CL 323i. Angiographic X-ray systems used in generating fluoroscopic and rotational images of human anatomy for diagnostic, interventional and image-guided surgical procedures.
Published July 8, 2015 · Recall initiated: May 29, 2015
Summary
FDA records medical device Class II recall Z-1985-2015, published July 8, 2015 and initiated May 29, 2015. Recalling firm: GE Healthcare; Status: Terminated; Reported quantity: 7; Lot: Serial Number System ID Not Available GON4271838 Not Available 229890CL Not Available 361788CL323 Not Available 806358INNOVA 0C2V069A4104R1 082416310033 0C2V069A4202R1 082416200021 0C2V069A4203R1 082416050013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
GE Healthcare has recently become aware of a potential safety issue that may result in the loss of C-arm gantry motion capability on fluoroscopic Interventional imaging systems (Innova, Optima and Discovery).
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- GE Healthcare
- Distributor
- Worldwide Distribution: US (nationwide) including states of: CA, DE, FL, GA, IL, IN, KS, MS, NV, OH, OK, OR, PA, TN, TX, VA, WA and WI; and countries of: ARGENTINA, BELGIUM, BRAZIL, CANADA, CHILE, CHINA, FRANCE, GERMANY, HONG KONG, HUNGARY, INDIA, INDONESIA, ITALY, JAPAN, RUSSIA, UNITED KINGDOM, and VIETNAM.
- Lot
- Serial Number System ID Not Available GON4271838 Not Available 229890CL Not Available 361788CL323 Not Available 806358INNOVA 0C2V069A4104R1 082416310033 0C2V069A4202R1 082416200021 0C2V069A4203R1 082416050013
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDACentricity Enterprise Archive V2, V3, and V4, software product for receiving, archiving, and sendingSeptember 23, 2026
- FDAWorkflow Core Services V8, intended to provide set of services for storage and retrieval of patient data,September 23, 2026
- FDACentricity PACS V2, V3, V4, V6, V7, software product is intended for the storage, reading, diagnostic review,September 23, 2026
- FDACore Services Hub V8, a set of backend services including Cross Enterprise (XE) and Workflow Core (WFC)September 23, 2026
- FDASLIM-K, 30 Capsules, barcode 160126417509, Distributed by: Bethel Inc.July 15, 2015
- FDAGE Healthcare Discovery IGS 730. Angiographic X-ray systems used in generating fluoroscopic and rotationalJuly 8, 2015
Questions about this recall
Was GE Healthcare Optima CL 323i. Angiographic X-ray systems used in generating fluoroscopic and rotational images of human anatomy for diagnostic, interventional and image-guided surgical procedures. recalled?
Yes. FDA published recall Z-1985-2015 on July 8, 2015. Reported hazard: GE Healthcare has recently become aware of a potential safety issue that may result in the loss of C-arm gantry motion capability on fluoroscopic Interventional imaging systems (Innova, Optima and Discovery).
What should I do if I have this product?
Voluntary: Firm initiated · Letter